The Imbalance in Expression of Angiogenic and Anti-angiogenic Factors As Candidate Predictive Biomarker in Preeclampsia

Overview

Journal Iran J Reprod Med

Specialty Reproductive Medicine

Date 2015 Jul 30

PMID 26221124

Citations 12

Authors

Pooneh Nikuei

Kianoosh Malekzadeh

Minoo Rajaei

Azim Nejatizadeh

Nasrin Ghasemi

Affiliations

Soon will be listed here.

Abstract

Preeclampsia is an important pregnancy disorder with serious maternal and fetal complications which its etiology has not been completely understood yet. Early diagnosis and management of disease could reduce its potential side effects. The vascular endothelial growth factor (VEGF) family including VEGF-A is the most potent endothelial growth factor which induces angiogenesis and endothelial cell proliferation and has basic role in vasculogenesis. VEGF and its tyrosine kinase receptors (Flt1 and KDR) are major factors for fetal and placental angiogenic development. Finding mechanisms involved in expression of angiogenic factors may lead to new prognostic and therapeutic points in management of preeclampsia. Recent researches, has shown capability of some anti-angiogenic factors as potential candidate to be used as early predictors for preeclampsia. Soluble fms-like tyrosin kinase-1 (sFlt1) is a truncated splice variant of the membrane-bound VEGF receptor Flt1, that is produced by the placenta and it can bind to angiogenic growth factors and neutraliz, their effects. It is also observed that the ratio of sFlt1 to placental growth factor is valuable as prognostic marker. In this review, VEGF family member's role in angiogenesis is evaluated as biomarkers to be used for prediction of preeclampsia.

Citing Articles

A Review of the Diagnosis, Risk Factors, and Role of Angiogenetic Factors in Hypertensive Disorders of Pregnancy.

Zielinska J, Darmochwal-Kolarz D Med Sci Monit. 2025; 31:e945628.

PMID: 40007059 PMC: 11871747. DOI: 10.12659/MSM.945628.

The Impact of Antiretroviral Therapy on Liver Function Among Pregnant Women Living with HIV in Co-Existence with and Without Pre-Eclampsia.

Strauss K, Phoswa W, Mokgalaboni K Viruses. 2025; 17(1).

PMID: 39861817 PMC: 11768528. DOI: 10.3390/v17010028.

Inhibition of FLT1 Attenuates Neurodevelopmental Abnormalities and Cognitive Impairment in Offspring Caused by Maternal Prenatal Stress.

Zhang H, Zhang Y, Xu K, Wang L, Zhou X, Yang M Appl Biochem Biotechnol. 2023; 196(8):4900-4913.

PMID: 37979086 DOI: 10.1007/s12010-023-04774-6.

Model for Early Prediction of Preeclampsia: A Nested Case Controlled Study in Indian Women.

Yadav S, Khandpur S, Yadav Y, Goel M, Singh U, Natu S J Obstet Gynaecol India. 2022; 72(4):299-306.

PMID: 35923506 PMC: 9339447. DOI: 10.1007/s13224-021-01511-z.

Serum From Preeclamptic Women Triggers Endoplasmic Reticulum Stress Pathway and Expression of Angiogenic Factors in Trophoblast Cells.

Castro K, Prado K, Lorenzon A, Hoshida M, Alves E, Francisco R Front Physiol. 2022; 12:799653.

PMID: 35185601 PMC: 8855099. DOI: 10.3389/fphys.2021.799653.

References

Lapaire O, Shennan A, Stepan H . The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application. Eur J Obstet Gynecol Reprod Biol. 2010; 151(2):122-9. DOI: 10.1016/j.ejogrb.2010.04.009. View

Vatten L, Romundstad P, Trichopoulos D, Skjaerven R . Pre-eclampsia in pregnancy and subsequent risk for breast cancer. Br J Cancer. 2002; 87(9):971-3. PMC: 2364313. DOI: 10.1038/sj.bjc.6600581. View

Diab A, El-Behery M, Ebrahiem M, Shehata A . Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry. Int J Gynaecol Obstet. 2008; 102(2):146-51. DOI: 10.1016/j.ijgo.2008.02.016. View

Unal E, Robinson C, Johnson D, Chang E . Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia. Am J Obstet Gynecol. 2007; 197(2):211.e1-4. DOI: 10.1016/j.ajog.2007.05.022. View

Kadyrov M, Kingdom J, Huppertz B . Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction. Am J Obstet Gynecol. 2006; 194(2):557-63. DOI: 10.1016/j.ajog.2005.07.035. View

Shibuya M, Claesson-Welsh L . Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res. 2005; 312(5):549-60. DOI: 10.1016/j.yexcr.2005.11.012. View

Jauniaux E, Poston L, Burton G . Placental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolution. Hum Reprod Update. 2006; 12(6):747-55. PMC: 1876942. DOI: 10.1093/humupd/dml016. View

Crispi F, Llurba E, Dominguez C, Martin-Gallan P, Cabero L, Gratacos E . Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol. 2007; 31(3):303-9. DOI: 10.1002/uog.5184. View

Sawano A, Takahashi T, Yamaguchi S, Aonuma M, Shibuya M . Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ. 1996; 7(2):213-21. View

10.

Ohkuchi A, Hirashima C, Suzuki H, Takahashi K, Yoshida M, Matsubara S . Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia. Hypertens Res. 2010; 33(5):422-7. DOI: 10.1038/hr.2010.15. View

11.

Foyouzi N, Norwitz E, Tsen L, Buhimschi C, Buhimschi I . Placental growth factor in the cerebrospinal fluid of women with preeclampsia. Int J Gynaecol Obstet. 2005; 92(1):32-7. DOI: 10.1016/j.ijgo.2005.09.004. View

12.

Zhou Y, Damsky C, Fisher S . Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?. J Clin Invest. 1997; 99(9):2152-64. PMC: 508045. DOI: 10.1172/JCI119388. View

13.

Muy-Rivera M, Vadachkoria S, Woelk G, Qiu C, Mahomed K, Williams M . Maternal plasma VEGF, sVEGF-R1, and PlGF concentrations in preeclamptic and normotensive pregnant Zimbabwean women. Physiol Res. 2005; 54(6):611-22. View

14.

Kim S, Ryu H, Yang J, Kim M, Han J, Kim J . Increased sFlt-1 to PlGF ratio in women who subsequently develop preeclampsia. J Korean Med Sci. 2007; 22(5):873-7. PMC: 2693856. DOI: 10.3346/jkms.2007.22.5.873. View

15.

Mutter W, Karumanchi S . Molecular mechanisms of preeclampsia. Microvasc Res. 2007; 75(1):1-8. PMC: 2241748. DOI: 10.1016/j.mvr.2007.04.009. View

16.

Naicker T, Khedun S, Moodley J, Pijnenborg R . Quantitative analysis of trophoblast invasion in preeclampsia. Acta Obstet Gynecol Scand. 2003; 82(8):722-9. DOI: 10.1034/j.1600-0412.2003.00220.x. View

17.

Reuvekamp A, Poulina I, Capello J, Duits A . Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol. 1999; 106(10):1019-22. DOI: 10.1111/j.1471-0528.1999.tb08107.x. View

18.

Fu G, Brkic J, Hayder H, Peng C . MicroRNAs in Human Placental Development and Pregnancy Complications. Int J Mol Sci. 2013; 14(3):5519-44. PMC: 3634453. DOI: 10.3390/ijms14035519. View

19.

Wang W, Feng L, Zhang H, Hachy S, Satohisa S, Laurent L . Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta. J Clin Endocrinol Metab. 2012; 97(6):E1051-9. PMC: 3387422. DOI: 10.1210/jc.2011-3131. View

20.

Shibata E, Rajakumar A, Powers R, Larkin R, Gilmour C, Bodnar L . Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab. 2005; 90(8):4895-903. DOI: 10.1210/jc.2004-1955. View